Press release
RNA Extraction and Purification Market to Reach USD 5.4 Billion by 2034
RNA Extraction and Purification
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72629
Market Overview
The global RNA extraction and purification market was valued at USD 1.9 billion in 2024 and is projected to reach USD 5.4 billion by 2034, growing at a CAGR of 10.9% during the forecast period.
Key Highlights:
• Market Size 2024: USD 1.9 billion
• Forecast 2034: USD 5.4 billion
• CAGR (2024-2034): 10.9%
• Primary Drivers: Expansion of RNA-based therapeutics, growing demand for molecular diagnostics, and rising investments in genomics research.
• Challenges: High cost of advanced kits, RNA's instability requiring specialized handling, and limited adoption in low-resource settings.
• Leading Players: Qiagen, Thermo Fisher Scientific, Bio-Rad Laboratories, Agilent Technologies, Takara Bio, Roche, Illumina, and Promega Corporation.
The market is evolving as an essential backbone of the life sciences sector, directly supporting innovations in precision medicine and RNA therapeutics.
Segmentation Analysis
By Product Type:
• Kits & reagents
• Instruments
• Services
By Technology:
• Column-based extraction
• Magnetic bead-based extraction
• Reagent-based extraction
• Others (automation platforms, microfluidics)
By Application:
• Gene expression studies
• Next-generation sequencing (NGS)
• Polymerase chain reaction (PCR)
• Microarray analysis
• Biomarker discovery
• Vaccine & drug development
• Others (forensic testing, agricultural genomics)
By End-User:
• Academic & research institutes
• Pharmaceutical & biotechnology companies
• Contract research organizations (CROs)
• Clinical & diagnostic laboratories
Summary:
The demand is strongest from NGS, PCR, and biomarker research, where RNA purity directly impacts results. Kits and reagents dominate product sales, while automation technologies are rising rapidly to improve efficiency and reproducibility.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72629/rna-extraction-and-rna-purification-market
Regional Analysis
North America
• Largest market due to advanced molecular biology research, strong biotech industry, and government funding for genomics and RNA therapeutics.
• U.S. leads with high adoption of NGS and clinical diagnostics.
Europe
• Germany, UK, and France drive growth with strong R&D investments and clinical adoption of RNA-based diagnostics.
• EU support for biotech accelerates uptake in precision medicine.
Asia-Pacific
• Fastest-growing region, led by China, Japan, India, and South Korea.
• Growth driven by expanding pharmaceutical manufacturing, cost-effective clinical trials, and government investments in genomic research.
Middle East & Africa
• Early-stage adoption, with increasing investments in diagnostic infrastructure.
• GCC countries leading the shift toward advanced molecular biology research.
Latin America
• Brazil and Mexico driving growth through expanding diagnostic centers and collaborations with international biotech firms.
Summary:
North America remains dominant, but Asia-Pacific is projected to record the fastest CAGR (12%+), becoming a major hub for RNA-based research and manufacturing by 2034.
Market Dynamics
Key Growth Drivers:
• Rising use of RNA-based therapies (mRNA vaccines, RNAi, antisense oligonucleotides).
• Growing demand for personalized medicine and precision oncology.
• Expansion of NGS and PCR-based diagnostic platforms.
• Increasing government and private funding for genomic research.
Key Challenges:
• High costs of specialized kits and instruments.
• Technical challenges in ensuring RNA integrity and stability.
• Limited adoption in underdeveloped healthcare markets.
Latest Trends:
• Development of automated, high-throughput RNA extraction platforms.
• Integration of AI and bioinformatics to enhance RNA sequencing and analysis.
• Increasing use of magnetic bead-based technologies for higher yield and purity.
• Growing collaborations between CROs, academic institutes, and pharmaceutical companies.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72629
Competitor Analysis
Major Players in the RNA Extraction and Purification Market:
• Qiagen - Leader in RNA purification kits and automation systems.
• Thermo Fisher Scientific - Strong portfolio in reagents, instruments, and NGS platforms.
• Bio-Rad Laboratories - Providing advanced RNA workflow solutions.
• Agilent Technologies - Offering integrated RNA analysis systems.
• Takara Bio - Focused on PCR and RNA-related reagents.
• Roche Diagnostics - Active in molecular diagnostics and RNA-based assay kits.
• Illumina - Driving RNA sequencing adoption through NGS platforms.
• Promega Corporation - Supplying reagents and RNA analysis kits globally.
Competitive Summary:
Competition is driven by product innovation, automation, and integration with sequencing workflows. Leading players are expanding partnerships with CROs and clinical labs to strengthen market presence. Emerging startups are targeting cost-effective, user-friendly solutions to capture growth in developing economies.
Conclusion
The RNA Extraction and RNA Purification Market is set to expand rapidly, reaching USD 5.4 billion by 2034. As RNA biology transitions from basic research to clinical applications, demand for high-quality RNA purification technologies will intensify.
Key Takeaways:
• Market to grow at 10.9% CAGR (2024-2034).
• Kits and reagents remain the largest product segment, with automation technologies gaining ground.
• North America leads in adoption, but Asia-Pacific will post the fastest growth.
• Key opportunities lie in mRNA vaccines, RNA therapeutics, and biomarker-driven diagnostics.
• Competition focuses on innovation, scalability, and workflow integration with sequencing platforms.
By enabling reliable, high-quality RNA analysis, this market is playing a pivotal role in advancing precision medicine, drug development, and next-generation diagnostics-making it an indispensable pillar of modern biotechnology.
This report is also available in the following languages : Japanese (RNA抽出およびRNA精製市場), Korean (RNA 추출 및 RNA 정제 시장), Chinese (RNA提取和RNA纯化市场), French (Marché de l'extraction et de la purification de l'ARN), German (Markt für RNA-Extraktion und RNA-Reinigung), and Italian (Mercato dell'estrazione e della purificazione dell'RNA), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72629/rna-extraction-and-rna-purification-market#request-a-sample
Our More Reports:
Non-fungible Tokens (NFT) in Healthcare Market
https://exactitudeconsultancy.com/reports/73689/non-fungible-tokens-nft-in-healthcare-market
Cognitive Assessment and Training In Healthcare Market
https://exactitudeconsultancy.com/reports/73690/cognitive-assessment-and-training-in-healthcare-market
Generative AI in Healthcare Market
https://exactitudeconsultancy.com/reports/73691/generative-ai-in-healthcare-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Extraction and Purification Market to Reach USD 5.4 Billion by 2034 here
News-ID: 4202158 • Views: …
More Releases from Exactitude Consultancy
A combination of anti-aging drug increases the lifetime of mice by 30% and gives …
The global Anti-Aging Drugs Market is entering a dynamic growth phase, fueled by advances in regenerative medicine, biotechnology, and preventive healthcare. As populations age worldwide, the demand for therapies that extend not just lifespan but healthspan-the number of years lived in good health-is accelerating. Anti-aging drugs aim to target biological mechanisms of aging, delay age-related diseases, and improve overall quality of life. With growing investment in longevity research, breakthroughs in…
FDA decision on relacorilant for Cushing's expected by year's end
Introduction
Cushing's syndrome is a rare but serious endocrine disorder caused by prolonged exposure to high cortisol levels. It can occur due to long-term use of corticosteroid medications or because of tumors that produce excess adrenocorticotropic hormone (ACTH). Symptoms such as weight gain, hypertension, diabetes, osteoporosis, and psychological changes significantly impact patients' quality of life.
Though rare, Cushing's syndrome has become an important therapeutic focus in endocrinology because of the severe health…
Advances in the Study of Macular Degeneration Addressing the Rising Global Burde …
Introduction
Macular degeneration, particularly age-related macular degeneration (AMD), is one of the leading causes of irreversible vision loss among adults over 50. It affects the macula - the central portion of the retina responsible for sharp, detailed vision. With aging populations and lifestyle-related risk factors on the rise, the global prevalence of AMD is growing at an alarming rate.
While treatments such as anti-VEGF (vascular endothelial growth factor) injections have transformed disease…
Baby healed in world's first gene-editing therapy; Indian-origin doctor plays ke …
Introduction
Genome editing has transitioned from a theoretical possibility to a transformative therapeutic reality. With tools such as CRISPR-Cas9, TALENs, and zinc finger nucleases (ZFNs), scientists can now make precise modifications to DNA sequences, correcting mutations at their source. This unprecedented capability is paving the way for treatments that cure genetic disorders, rather than just managing symptoms.
The genome editing therapy market is poised for strong growth as pharmaceutical and biotech firms…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
